Ultraviolet-C light makes benzalkonium chloride, which is found in many disinfectants, safer to use.
Applying germicidal ultraviolet-C (UVC) light to common disinfectants could make them safer to use and could also help them to better fight COVID-19, according to investigators with the University of Waterloo in Ontario, Canada.
Results from their study were published in the journal Cutaneous and Ocular Toxicology.
“With concerns about the spread of COVID-19, people are utilizing products with BAK as an active ingredient more than ever,” said Manlong Xu, the study’s lead author. “For many industries, there is the demand to improve the efficacy of standard disinfection procedures, while also keeping in mind any potential negative impact on the environment.”
Benzalkonium chloride (BAK), one of the most common active ingredients in many disinfectants that are used in households, food processing plants and hospitals, cannot be used in high concentrations due to its toxicity.
However, in order to protect against harmful viruses and bacteria, high concentrations of BAK are needed, and the residue can harm the environment and people.
For the study, investigators exposed a BAK solution to UVC lamps and then applied the solution to cultured human corneal cells. After 5 minutes, they analyzed the cells for metabolic activity, as well as viability, and found that the BAK solution was neutralized by the UVC and did not harm the cells.
“Our results show that a disinfecting procedure using BAK followed by UVC radiation can minimize the harmful effect of BAK residues on humans and the environment,” David McCanna of Waterloo's Department of Optometry & Vision Science said. “Such a procedure also has a great potential to maximize the disinfection efficacy by utilizing two different antimicrobial mechanisms. As the pandemic continues, our findings are especially important as it provides another method to make our hospitals, food, homes, and the environment safer.”
This story originally appeared in Contagion®.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies